EUVIMEDEUVIMED entdecken
Crossref

Monitoring CD3(+) T Cells in Kidney Transplantation and Immunosuppression Adequacy

Kemal Eyvaz, Arif Aslaner, Arif Ata Kiravkazli

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.06.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Kemal Eyvaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery and Organ Trasnplantation, University of Health Sciences -Antalya Health Research Center, Antalya, Turkey. Electronic a…. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, T-Lymphocytes, Immunosuppression Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Monitoring CD3(+) T-cell counts in kidney transplant recipients can provide valuable insights into immunosuppressive therapy effectiveness. This study aimed to evaluate the use of CD3(+) T-cell levels as biomarkers for immunosuppression adequacy and to assess their predictive value for acute rejection post-transplantation. METHODS: A retrospective review was conducted involving 130 kidney transplant recipients who received induction therapy with antithymocyte globulin (ATG). CD3(+) T-cell percentages and absolute counts were measured using flow cytometry on postoperative day 5. Immunosuppression was maintained with tacrolimus, initiated upon clinical indicators of graft function recovery. RESULTS: Among monitored patients, the median CD3(+) T-cell percentage was 48%, and median absolute count was 0.14 × 10⁹/L. Acute rejection occurred in 9.9% of recipients. Higher CD3(+) T-cell values significantly correlated with acute rejection (64.0% vs 47.5%, p = .011; absolute count 0.28 vs 0.13 × 10⁹/L, p = .032). ROC analysis identified optimal predictive thresholds: 54% for CD3(+) percentage (sensitivity 85.7%, specificity 73.4%) and 0.21 × 10⁹/L for absolute count (sensitivity 85.7%, specificity 75.0%). CONCLUSIONS: CD3(+) T-cell monitoring effectively guides individualized immunosuppressive strategies, significantly predicting acute rejection risks and optimizing graft outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationGraft RejectionT-LymphocytesImmunosuppression TherapyMonitoring, ImmunologicRetrospective StudiesAntilymphocyte SerumCD3 ComplexImmunosuppressive AgentsTacrolimusLymphocyte CountBiomarkersROC CurvePredictive Value of TestsRisk AssessmentKidney Failure, ChronicHumansMaleFemaleYoung AdultAdultMiddle AgedAged

Substanzen

Antilymphocyte SerumCD3 ComplexImmunosuppressive AgentsTacrolimusBiomarkers

Autor:innen und Institutionen

  • Department of General Surgery and Organ Trasnplantation, University of Health Sciences -Antalya Health Research Center, Antalya, Turkey. Electronic address: drkemal07@gmail.com.
  • Department of General Surgery and Organ Trasnplantation, University of Health Sciences -Antalya Health Research Center, Antalya, Turkey.

Zitieren

APA

Eyvaz, K., Aslaner, A., & Kiravkazli, A. A. (2025). Monitoring CD3(+) T Cells in Kidney Transplantation and Immunosuppression Adequacy. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.06.016

Vancouver

Eyvaz K, Aslaner A, Kiravkazli AA. Monitoring CD3(+) T Cells in Kidney Transplantation and Immunosuppression Adequacy. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.06.016

BibTeX
@article{Eyvaz2025,
  author = {Eyvaz, Kemal and Aslaner, Arif and Kiravkazli, Arif Ata},
  title = {Monitoring CD3(+) T Cells in Kidney Transplantation and Immunosuppression Adequacy},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.06.016}
}
Kostenlos starten →